Targeting TYK2 in Cutaneous Autoimmunity: Deucravacitinib-Induced Remission of Discoid Lupus and Psoriasis with Supportive Confocal Microscopy Findings

Abstract Introduction Cutaneous lupus erythematosus (CLE), particularly discoid lupus erythematosus (DLE), is a chronic autoimmune condition driven in part by type I interferon signaling. No systemic therapies are specifically approved for CLE, and management is often extrapolated from systemic lupu...

詳細記述

書誌詳細

主要な著者:	Francesco D’Oria, Francesco Piscazzi, Paola Facheris, Giulio Foggi, Marco Ardigò, Antonio Costanzo, Mario Valenti
フォーマット:	Artigo
言語:	Inglês
出版事項:	Adis, Springer Healthcare 2026-04-01
シリーズ:	Dermatology and Therapy
主題:	Discoid lupus erythematosus Cutaneous lupus erythematosus Deucravacitinib TYK2 inhibition Plaque psoriasis
オンライン･アクセス:	https://doi.org/10.1007/s13555-026-01742-w
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!